LIVER FASt ™

Blood-based liver evaluation test that uses 10 biomarkers and advanced technology to determine the condition of the liver

  • What is LIVERFASt™
  • How it works
  • What does it measure
  • Clinical Validation
  • Integration and Usability

What is LIVERFASt™?

LIVERFASt™ provides a score from 0.00 to 1.00 and its estimated grade or stage, similar to the histopathological scoring of the liver (based on the liver biopsy classification).

  • Alpha-2-Macroglobulin

  • Haptoglobin

  • Apolipoprotein A1

  • Total Bilirubin

  • GGT

  • ALT

  • AST

  • Fasting Glucose

  • Triglycerides

  • Total Cholesterol

How it Works

Simple and easy-to-do

Physician prescribes LIVERFASt™

Lab analyzes 10 biomarkers from 1 blood draw

Biomarker values plus age, height, weight, gender, are entered into the platform

LIVERFASt™ results are available immediately.

What does LIVERFASt™ Measure?

LIVERFASt™ takes inputs from 10 biomarkers and patient anthropometrics to generate a score from 0.00 to 1.00 that corresponds to the histopathological staging of a liver biopsy.

Fibrosis

STAGE

FO INTERPRETATION
No fibrosis F1
F2 Advanced fibrosis
F1 Significant fibrosis
F4 Severe fibrosis/cirrhosis

Activity

STAGE

aO INTERPRETATION
No activity a1
a2 Moderate activity
a1 Marked activity
a4 Severe activity

Steatosis

STAGE

sO INTERPRETATION
No steatosis (<5%) s1
s2 Moderate steatosis (34-66%)
s3 Marked steatosis (≥ 67%)

Clinical Validation

LIVERFASt™ is clinically validated against different cohorts and can be used to test patients with different comorbidities.

LIVIRFASt Activity Test performance

MASLD population(n=223)

Metric Value
ADRDC (95% CI) 0.79 (0.71-0.85)
Specificity 0.85
Sensitivity 0.59
Negative Predictive Value 0.65
Positive Predictive Value 0.85

LIVIRFASt Fibrosis Test performance

MASLD population(n=223)

Metric Value
ADRDC (95% CI) 0.867 (0.807-0.910)
Specificity 0.85
Sensitivity 0.75
Negative Predictive Value 0.88
Positive Predictive Value 0.71

The concordance for cirrhosis with Liver Biopsy (n=452)

Test Positive
LIVERFASt 67/95(71%)
LSM 51/95(54%)
FIB-4 45/95(47%)

Integration and Usability

LIVERFASt™ seamlessly integrates into any clinical or healthcare setting, enhancing liver health screening workflows without disrupting existing systems.

Interested in LIVERFASt™?

Sign up with us to receive exclusive brochures and posters that provide detailed insights into groundbreaking products.